DexCom
DXCM
#894
Rank
A$38.84 B
Marketcap
A$99.04
Share price
0.75%
Change (1 day)
-21.35%
Change (1 year)

Operating Margin for DexCom (DXCM)

Operating Margin as of December 2025 (TTM): 17.57%

According to DexCom's latest financial reports and stock price the company's current Operating Margin is 17.57%. At the end of 2024 the company had an Operating Margin of 17.58%.

Operating Margin history for DexCom from 2006 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202417.58%-10.36%
202319.61%46.02%
202213.43%28.05%
202110.49%-10.19%
202011.68%65.42%
20197.06%-157.57%
2018-12.26%81.29%
2017-6.76%-40.25%
2016-11.32%-20.86%
2015-14.30%66.25%
2014-8.60%-53.81%
2013-18.63%-66.66%
2012-55.86%-4.66%
2011-58.58%-48.42%
2010-113.58%-36.99%
2009-180.26%-66.43%
2008-536.97%-46.77%
2007-1,008.77%-55.62%
2006-2,272.81%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Edwards Lifesciences
EW
29.01% 65.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
8.81%-49.86%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical
WST
20.02% 13.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-20.35%-215.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
16.78%-4.50%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Abbott Laboratories
ABT
18.56% 5.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
18.78% 6.89%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-41.85%-338.19%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.